HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
CARD9
caspase recruitment domain family member 9
Chromosome 9 Β· 9q34.3
NCBI Gene: 64170Ensembl: ENSG00000187796.17HGNC: HGNC:16391UniProt: Q9H257
124PubMed Papers
21Diseases
0Drugs
24Pathogenic Variants
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
positive regulation of stress-activated MAPK cascadepositive regulation of JNK cascadeprotein bindingsignaling adaptor activityChronic mucocutaneous candidosisinflammatory bowel diseaseCrohn's diseaseIGA glomerulonephritis
✦AI Summary

CARD9 (Caspase Recruitment Domain Family Member 9) is a critical adapter protein that mediates innate immune responses, particularly against fungal pathogens. The protein functions downstream of C-type lectin receptors such as Dectin-1, forming signaling complexes that activate NF-ΞΊB and MAPK pathways to promote inflammatory cytokine production 1. CARD9 operates through the CBM (CARD9-BCL10-MALT1) complex, which can be regulated by deubiquitination via OTUD1 2. Beyond antifungal immunity, CARD9 plays essential roles in gut microbiota regulation by influencing tryptophan metabolism into aryl hydrocarbon receptor ligands, with Card9-deficient mice showing altered microbiota composition and increased colitis susceptibility 3. The protein also functions in neutrophil-mediated immune responses, where it promotes Th17 cell expansion and contributes to inflammatory diseases like ankylosing spondylitis 4. CARD9 polymorphisms are associated with increased susceptibility to fungal infections and inflammatory bowel disease, mechanistically involving impaired cytokine production and defective neutrophil function 5. The protein's diverse functions extend to regulating intestinal inflammation, with Card9-knockout mice showing increased susceptibility to colitis due to disrupted IL-22 production and altered gut microbiome metabolism 3.

Sources cited
1
CARD9 functions downstream of Dectin-1 receptor via Ξ²-glucan/Dectin-1/CARD9 pathway promoting IL-1Ξ² secretion
PMID: 37738973
2
CARD9 operates through CBM complex and is regulated by OTUD1-mediated deubiquitination to activate NF-ΞΊB signaling
PMID: 39118286
3
CARD9 regulates gut microbiota composition and tryptophan metabolism, affecting colitis susceptibility through IL-22 production
PMID: 27158904
4
CARD9 in neutrophils promotes Th17 cell expansion and contributes to ankylosing spondylitis pathogenesis
PMID: 37813481
5
CARD9 polymorphisms are associated with increased susceptibility to fungal infections and inflammatory diseases through impaired immune function
PMID: 34690098
Disease Associationsβ“˜21
Chronic mucocutaneous candidosisOpen Targets
0.76Strong
inflammatory bowel diseaseOpen Targets
0.44Moderate
Crohn's diseaseOpen Targets
0.41Moderate
IGA glomerulonephritisOpen Targets
0.41Moderate
ulcerative colitisOpen Targets
0.40Moderate
deep seated dermatophytosisOpen Targets
0.37Weak
ankylosing spondylitisOpen Targets
0.35Weak
immunodeficiency diseaseOpen Targets
0.34Weak
dermatomycosisOpen Targets
0.34Weak
sclerosing cholangitisOpen Targets
0.32Weak
psoriasisOpen Targets
0.32Weak
dermatophytosisOpen Targets
0.26Weak
colitisOpen Targets
0.20Weak
genetic disorderOpen Targets
0.19Weak
enteritisOpen Targets
0.17Weak
infectionOpen Targets
0.10Suggestive
neoplasmOpen Targets
0.09Suggestive
arthritisOpen Targets
0.08Suggestive
atherosclerosisOpen Targets
0.08Suggestive
SepsisOpen Targets
0.08Suggestive
Immunodeficiency 103, susceptibility to fungal infectionsUniProt
Pathogenic Variants24
NM_052813.5(CARD9):c.865C>T (p.Gln289Ter)Pathogenic
Predisposition to invasive fungal disease due to CARD9 deficiency
β˜…β˜…β˜†β˜†2025β†’ Residue 289
NM_052813.5(CARD9):c.883C>T (p.Gln295Ter)Pathogenic
Predisposition to invasive fungal disease due to CARD9 deficiency
β˜…β˜…β˜†β˜†2025β†’ Residue 295
NM_052813.5(CARD9):c.820dup (p.Asp274fs)Pathogenic
Predisposition to invasive fungal disease due to CARD9 deficiency
β˜…β˜…β˜†β˜†2023β†’ Residue 274
NM_052813.5(CARD9):c.1351_1354del (p.Asp451fs)Pathogenic
Predisposition to invasive fungal disease due to CARD9 deficiency
β˜…β˜…β˜†β˜†2022β†’ Residue 451
NM_052813.5(CARD9):c.475G>T (p.Glu159Ter)Pathogenic
Predisposition to invasive fungal disease due to CARD9 deficiency
β˜…β˜†β˜†β˜†2025β†’ Residue 159
NM_052813.5(CARD9):c.1357+1G>ALikely pathogenic
Predisposition to invasive fungal disease due to CARD9 deficiency
β˜…β˜†β˜†β˜†2025
NM_052813.5(CARD9):c.807+1G>TLikely pathogenic
Predisposition to invasive fungal disease due to CARD9 deficiency
β˜…β˜†β˜†β˜†2024
NM_052813.5(CARD9):c.1213C>T (p.Gln405Ter)Pathogenic
Predisposition to invasive fungal disease due to CARD9 deficiency
β˜…β˜†β˜†β˜†2024β†’ Residue 405
NM_052813.5(CARD9):c.766del (p.Leu256fs)Pathogenic
Predisposition to invasive fungal disease due to CARD9 deficiency
β˜…β˜†β˜†β˜†2023β†’ Residue 256
NM_052813.5(CARD9):c.808-1G>CLikely pathogenic
Predisposition to invasive fungal disease due to CARD9 deficiency
β˜…β˜†β˜†β˜†2023
NM_052813.5(CARD9):c.1358-1G>ALikely pathogenic
Predisposition to invasive fungal disease due to CARD9 deficiency
β˜…β˜†β˜†β˜†2023
NM_052813.5(CARD9):c.1000A>T (p.Lys334Ter)Pathogenic
Predisposition to invasive fungal disease due to CARD9 deficiency
β˜…β˜†β˜†β˜†2023β†’ Residue 334
NM_052813.5(CARD9):c.205C>T (p.Gln69Ter)Pathogenic
Predisposition to invasive fungal disease due to CARD9 deficiency
β˜…β˜†β˜†β˜†2023β†’ Residue 69
NM_052813.5(CARD9):c.1078-1G>ALikely pathogenic
Predisposition to invasive fungal disease due to CARD9 deficiency
β˜…β˜†β˜†β˜†2023
NM_052813.5(CARD9):c.579dup (p.Glu194Ter)Pathogenic
Predisposition to invasive fungal disease due to CARD9 deficiency
β˜…β˜†β˜†β˜†2023β†’ Residue 194
NM_052813.5(CARD9):c.1045C>T (p.Gln349Ter)Pathogenic
Predisposition to invasive fungal disease due to CARD9 deficiency
β˜…β˜†β˜†β˜†2022β†’ Residue 349
NM_052813.5(CARD9):c.106C>T (p.Gln36Ter)Pathogenic
Predisposition to invasive fungal disease due to CARD9 deficiency
β˜…β˜†β˜†β˜†2022β†’ Residue 36
NM_052813.5(CARD9):c.273C>G (p.Tyr91Ter)Pathogenic
Predisposition to invasive fungal disease due to CARD9 deficiency
β˜…β˜†β˜†β˜†2022β†’ Residue 91
NM_052813.5(CARD9):c.575del (p.Gln192fs)Pathogenic
Predisposition to invasive fungal disease due to CARD9 deficiency
β˜…β˜†β˜†β˜†2022β†’ Residue 192
NM_052813.5(CARD9):c.1348_1349del (p.Ser450fs)Pathogenic
Predisposition to invasive fungal disease due to CARD9 deficiency
β˜…β˜†β˜†β˜†2021β†’ Residue 450
View on ClinVar β†—
Related Genes
TRAF6Protein interaction99%IKBKGProtein interaction99%CLEC4DProtein interaction99%IKBKBProtein interaction97%RIPK2Protein interaction97%NOD1Protein interaction97%
Tissue Expression6 tissues
Bone Marrow
100%
Lung
27%
Liver
11%
Ovary
4%
Heart
2%
Brain
2%
Gene Interaction Network
Click a node to explore
CARD9TRAF6IKBKGCLEC4DIKBKBRIPK2NOD1
PROTEIN STRUCTURE
Preparing viewer…
PDB6E28 Β· 1.36 Γ… Β· X-ray
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
1.14LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF0.91 [0.73–1.14]
RankingsWhere CARD9 stands among ~20K protein-coding genes
  • #3,785of 20,598
    Most Researched124 Β· top quartile
  • #2,009of 5,498
    Most Pathogenic Variants24
  • #11,871of 17,882
    Most Constrained (LOEUF)1.14
Genes detectedCARD9
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
The intratumor mycobiome promotes lung cancer progression via myeloid-derived suppressor cells.
PMID: 37738973
Cancer Cell Β· 2023
1.00
2
Dectin-1 facilitates lung fungal-mediated pulmonary fibrosis.
PMID: 40494347
Immunity Β· 2025
0.90
3
Neutrophils: from IBD to the gut microbiota.
PMID: 38110547
Nat Rev Gastroenterol Hepatol Β· 2024
0.80
4
Macrophage OTUD1-CARD9 axis drives isoproterenol-induced inflammatory heart remodelling.
PMID: 39118286
Clin Transl Med Β· 2024
0.70
5
Card9/neutrophil signalling axis promotes IL-17A-mediated ankylosing spondylitis.
PMID: 37813481
Ann Rheum Dis Β· 2024
0.60